Mr. Ramzi Benamar reports

BELLUS HEALTH ANNOUNCES MEETING UPDATES

BELLUS Health Inc. has released the meeting and record dates for the special meeting of shareholders to be held in connection with the acquisition of the company by GSK PLC for $2.0-billion (U.S.) pursuant to a plan of arrangement. The company will hold the acquisition meeting to consider the acquisition on June 16, 2023. The company's board of directors has unanimously recommended that its shareholders vote in favour of the approval of the acquisition. The record date for the acquisition meeting will be May 15, 2023.

The company announced today that it is postponing until June 30, 2023, its annual and special meeting of shareholders previously scheduled to be held on May 4, 2023. The new record date for the annual meeting will be May 25, 2023, and meeting materials will be sent to shareholders of record in due course. The company believes that the postponement is in the best interests of the company as it will allow management to focus its efforts on preparing for the acquisition meeting, the completion of the acquisition and completing its customary Q1 financial reporting.

The acquisition remains subject to regulatory approvals and approval of shareholders at the acquisition meeting.